CXCL10 and acute lymphoblastic leukemia: Notably, pharmacological inhibition with the CXCR3 antagonist AMG487 recapitulated the effects of genetic loss of CXCR3, reducing T-ALL cell migration to CXCL10, while forced CXCR3 expression was sufficient to drive leukemic cells to the meninges.